Lucio Iannone

Lucio Iannone, Head of Health Venture Investments at Leaps by Bayer, is a seasoned biotech investor with a PhD from Imperial College. He discusses how Leaps is revolutionizing biotech investing with significant early checks and strategic acquisitions like BlueRock. Lucio shares insights on key investment principles, including the importance of medical need and scientific credibility. He also contrasts the US and European biotech landscapes, offers advice for founders seeking VC support, and highlights the focus on longevity and preventative health in their strategies.